1. A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin;Levy;Circulation,1993
2. Efficacy and safety of fluvastatin in hypertensive patients;Peters,1993
3. Sandoz Research Institute data on file,1992